Biomarkers: A definite plus in pneumonia

Mediators of Inflammation

Volumn 2009, Issue , 2009, Pages

  Qu, Jie Ming ^a   Summah, Hanssa ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; CYTOKINE; ENDOTOXIN; HYDROCORTISONE; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG; CALCITONIN; COPEPTINS; DIAGNOSTIC AGENT; GLYCOPEPTIDE; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; PROTEIN PRECURSOR; TREM1 PROTEIN, HUMAN;

CLINICAL RESEARCH; COUGHING; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; LEUKOCYTE COUNT; PNEUMONIA; PRIORITY JOURNAL; REVIEW; METABOLISM; MORTALITY;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; ENDOTOXINS; GLYCOPEPTIDES; HUMANS; HYDROCORTISONE; MEMBRANE GLYCOPROTEINS; PNEUMONIA; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC;

EID: 71449111732     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2009/675753     Document Type: Review

References (92)

1. Sharma S., Maycher B., Eschun G., Radiological imaging in pneumonia: recent innovations Current Opinion in Pulmonary Medicine 2007 13 3 159 169
2. Schuetz P., Christ-Crain M., Mueller B., Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infectionshope for hype? Swiss Medical Weekly 2009 139 23-24 318 326
3. Pvoa P., C-reactive protein: a valuable marker of sepsis Intensive Care Medicine 2002 28 3 235 243
4. Du Clos T. W., C-reactive protein as a regulator of autoimmunity and inflammation Arthritis Rheumatism 2003 48 6 1475 1477
5. Hutchinson W. L., Koenig W., Frhlich M., Sund M., Lowe G. D. O., Pepys M. B., Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population Clinical Chemistry 2000 46 7 934 938
6. Clyne B., Olshaker J. S., The C-reactive protein Journal of Emergency Medicine 1999 17 6 1019 1025
7. Melbye H., Stocks N., Point of care testing for C-reactive proteina new path for Australian GPs? Australian Family Physician 2006 35 7 513 517
8. Flanders S. A., Stein J., Shochat G., Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough American Journal of Medicine 2004 116 8 529 535
9. Almirall J., Bolbar I., Toran P., Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Chest 2004 125 4 1335 1342
10. Garca Vzquez E., Martnez J. A., Mensa J., C-reactive protein levels in communityacquired pneumonia European Respiratory Journal 2003 21 702 705
11. Lehtomaki K., Leinonen M., Takala A., Hovi T., Herva E., Koskela M., Etiological diagnosis of pneumonia in military conscripts by combined use of bacterial culture and serological methods European Journal of Clinical Microbiology and Infectious Diseases 1988 7 3 348 354
12. Ortqvist A., Hedlund J., Wretlind B., Carlstrom A., Kalin M., Diagnostic and prognostic value of Interleukin-6 and C-reactive protein in community-acquired pneumonia Scandinavian Journal of Infectious Diseases 1995 27 5 457 462
13. Offidani M., Corvatta L., Malerba L., Piersantelli M.-N., Manso E., Leoni P., Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignancies Supportive Care in Cancer 2006 14 8 874 877
14. Adnet F., Borron S. W., Vicaut E., Value of C-reactive protein in the detection of bacterial contamination at the time of presentation in drug-induced aspiration pneumonia Chest 1997 112 2 466 471
15. Smith R. P., Lipworth B. J., C-reactive protein in simple community-acquired pneumonia Chest 1995 107 4 1028 1031
16. Marcus N., Mor M., Amir L., Mimouni M., Waisman Y., Validity of the quick-read C-reactive protein test in the prediction of bacterial pneumonia in the pediatric emergency department European Journal of Emergency Medicine 2008 15 3 158 161
17. Flood R. G., Badik J., Aronoff S. C., The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children Pediatric Infectious Disease Journal 2008 27 2 95 99
18. Heiskanen-Kosma T., Korppi M., Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings Scandinavian Journal of Infectious Diseases 2000 32 4 399 402
19. Toikka P., Irjala K., Juvn T., Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children Pediatric Infectious Disease Journal 2000 19 7 598 602
20. Pvoa P., Coelho L., Almeida E., C-reactive protein as a marker of infection in critically ill patients Clinical Microbiology and Infection 2005 11 2 101 108
21. van der Meer V., Neven A. K., van den Broek P. J., Assendelft W. J. J., Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review British Medical Journal 2005 331 7507 26 29
22. Coelho L., Pvoa P., Almeida E., Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course Critical Care 2007 11 R92
23. Chastre J., Luyt C.-E., Trouillet J.-L., Combes A., New diagnostic and prognostic markers of ventilator-associated pneumonia Current Opinion in Critical Care 2006 12 5 446 451
24. Maier M., Wutzler S., Lehnert M., Serum procalcitonin levels in patients with multiple injuries including visceral trauma Journal of Trauma 2009 66 1 243 249
25. Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schttler J., Postoperative plasma concentrations of procalcitonin after different types of surgery Intensive Care Medicine 1998 24 7 680 684
26. Brunkhorst F. M., Clark A. L., Forycki Z. F., Anker S. D., Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation International Journal of Cardiology 1999 72 1 11 22
27. Carsin H., Assicot M., Feger F., Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF and endotoxin levels early after thermal injury Burns 1997 23 3 218 224
28. Tseng J.-S., Chan M.-C., Hsu J.-Y., Kuo B. I.-T., Wu C.-L., Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia Respirology 2008 13 4 505 509
29. Rau B., Steinbach G., Gansauge F., Mayer J. M., Grunert A., Beger H. G., The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis Gut 1997 41 6 832 840 (Pubitemid 28023189)
30. Jung D.-Y., Park J. B., Lee E.-N., Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients Transplant Immunology 2008 18 4 338 343
31. Shehabi Y., Seppelt I., Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Critical Care 2008 12 3 211
32. Ball P., Baquero F., Cars O., Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence Journal of Antimicrobial Chemotherapy 2002 49 1 31 40
33. Prat C., Lacoma A., Dominguez J., Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia Journal of Infection 2007 55 5 400 407
34. Christ-Crain M., Stolz D., Bingisser R., PCT-guided antibiotic therapy in CAP American Journal of Respiratory and Critical Care Medicine 2006 174 84 93
35. Briel M., Schuetz P., Mueller B., Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care Archives of Internal Medicine 2008 168 18 2000 2007
36. Mira J.-P., Max A., Burgel P.-R., The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy Critical Care 2008 12 supplement 6 S5
37. Masi M., Gutirrez F., Shum C., Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index Chest 2005 128 4 2223 2229
38. Gendrel D., Raymon J., Coste J., Procalcitonin in community-acquired pneumonia: comparison with interleukin-6, C-reactive protein, and interferon-alpha for diagnosis of bacterial vs. viral infections in children 39 Proceedings of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 99) September 1999 San Francisco, Calif, USA 237. abstract no. 2124
39. Korppi M., Don M., Valent F., Canciani M., The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children Acta Paediatrica 2008 97 7 943 947
40. Franzin L., Cabodi D., Legionella pneumonia and serum procalcitonin Current Microbiology 2005 50 1 43 46
41. Haeuptle J., Zaborsky R., Fiumefreddo R., Prognostic value of procalcitonin in Legionella pneumonia European Journal of Clinical Microbiology and Infectious Diseases 2009 28 1 55 60
42. Nicolcescu P., Bdulescu F., Schenker M., Diagnosis of nosocomial pneumonia: conventional and new indicators Pneumologia 2006 55 2 52 57
43. Pelosi P., Barassi A., Severgnini P., Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury Chest 2008 134 1 101 108
44. Ramirez P., Garcia M. A., Ferrer M., Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia European Respiratory Journal 2008 31 2 356 362
45. Duflo F., Debon R., Monneret G., Bienvenu J., Chassard D., Allaouchiche B., Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia Anesthesiology 2002 96 1 74 79
46. Linssen C. F. M., Bekers O., Drent M., Jacobs J. A., C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia Annals of Clinical Biochemistry 2008 45 3 293 298
47. Luyt C.-E., Combes A., Reynaud C., Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia Intensive Care Medicine 2008 34 8 1434 1440
48. Stolz D., Stulz A., Mller B., Gratwohl A., Tamm M., BAL neutrophils, serum procalcitonin, and C-reactive protein to predict bacterial infection in the immunocompromised host Chest 2007 132 2 504 514
49. Schleicher G. K., Herbert V., Brink A., Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia European Respiratory Journal 2005 25 4 688 692
50. Mller B., Harbarth S., Stolz D., Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia BMC Infectious Diseases 2007 7, article 10
51. Hatherill M., Tibby S. M., Sykes K., Turner C., Murdoch I. A., Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count Archives of Disease in Childhood 1999 81 5 417 421
52. Simon L., Gauvin F., Amre D. K., Saint-Louis P., Lacroix J., Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis Clinical Infectious Diseases 2004 39 2 206 217
53. Hedlund J., Hansson L.-O., Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis Infection 2000 28 2 68 73
54. Holm A., Pedersen S. S., Nexoe J., Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care British Journal of General Practice 2007 57 540 555 560
55. Oppert M., Reinicke A., Mller C., Barckow D., Frei U., Eckardt K.-U., Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation Resuscitation 2002 53 2 167 170
56. Bouchon A., Dietrich J., Colonna M., Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes Journal of Immunology 2000 164 10 4991 4995
57. Soto G. J., Diagnostic strategies for nosocomial pneumonia Current Opinion in Pulmonary Medicine 2007 13 3 186 191
58. Phua J., Koay E. S. C., Zhang D., Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections European Respiratory Journal 2006 28 4 695 702
59. Gibot S., Cravoisy A., Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection Clinical Medicine Research 2004 2 3 181 187
60. Tejera A., Santolaria F., Diez M.-L., Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response Cytokine 2007 38 3 117 123
61. El Solh A. A., Akinnusi M. E., Peter M., Berim I., Schultz M. J., Pineda L., Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes Intensive Care Medicine 2008 34 6 1012 1019
62. Richeldi L., Mariani M., Losi M., Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections European Respiratory Journal 2004 24 2 247 250
63. Gibot S., Cravoisy A., Levy B., Bene M.-C., Faure G., Bollaert P.-E., Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia The New England Journal of Medicine 2004 350 5 451 458
64. Huh J. W., Lim C.-M., Koh Y., Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates Critical Care 2008 12 1 R6
65. Determann R. M., Millo J. L., Gibot S., Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia Intensive Care Medicine 2005 31 11 1495 1500
66. Horonenko G., Hoyt J. C., Robbins R. A., Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report Chest 2007 132 1 58 63
67. Chao W.-C., Wang C.-H., Chan M.-C., Chow K.-C., Hsu J.-Y., Wu C.-L., Predictive value of serial measurements of sTREM-1 the treatment response of patient with community-acquired pneumonia Journal of the Formosan Medical Association 2007 106 3 187 195
68. Gibot S., Cravoisy A., Dupays R., Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis Scandinavian Journal of Infectious Diseases 2007 39 6-7 604 608
69. Christ-Crain M., Schuetz P., Mller B., Biomarkers in the management of pneumonia Expert Review of Respiratory Medicine 2008 2 5 565 572
70. Pvoa P., Serum markers in community-acquired pneumonia and ventilator-associated pneumonia Current Opinion in Infectious Diseases 2008 21 2 157 162
71. Pugin J., Auckenthaler R., Delaspre O., van Gessel E., Suter P. M., Rapid diagnosis of gram negative pneumonia by assay of endotoxin in bronchoalveolar lavage fluid Thorax 1992 47 7 547 549
72. Flanagan P. G., Jackson S. K., Findlay G., Diagnosis of Gram negative, ventilator associated pneumonia by assaying endotoxin in bronchial lavage fluid Journal of Clinical Pathology 2001 54 2 107 110
73. Nys M., Ledoux D., Canivet J.-L., de Mol P., Lamy M., Damas P., Correlation between endotoxin level and bacterial count in bronchoalveolar lavage fluid of ventilated patients Critical Care Medicine 2000 28 8 2825 2830
74. Holwerda D. A., A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization European Journal of Biochemistry 1972 28 3 334 339
75. Holwerda D. A., A glycopeptide from the posterior lobe of pig pituitaries. 2. Primary structure European Journal of Biochemistry 1972 28 3 340 346
76. Robertson G. L., Antidiuretic hormone: normal and disordered function Endocrinology and Metabolism Clinics of North America 2001 30 3 671 694
77. Land H., Schutz G., Schmale H., Richter D., Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor Nature 1982 295 5847 299 303
78. Morgenthaler N. G., Struck J., Alonso C., Bergmann A., Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clinical Chemistry 2006 52 1 112 119
79. Morgenthaler N. G., Struck J., Jochberger S., Dunser M. W., Copeptin: clinical use of a new biomarker Trends in Endocrinology and Metabolism 2008 19 2 43 49
80. Mller B., Morgenthaler N., Stolz D., Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections European Journal of Clinical Investigation 2007 37 2 145 152
81. Seligman R., Papassotiriou J., Morgenthaler N. G., Meisner M., Teixeira P. J. Z., Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia Critical Care 2008 12 1 R11
82. Levin E. R., Gardner D. G., Samson W. K., Natriuretic peptides The New England Journal of Medicine 1998 339 5 321 328
83. Seligman R., Papassotiriou J., Morgenthaler N. G., Meisner M., Teixeira P. J. Z., Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia Intensive Care Medicine 2008 34 11 2084 2091
84. Prat C., Lacoma A., Dominguez J., Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia Journal of Infection 2007 55 5 400 407
85. http://www.innovations-report.com/html/reports/lifesciences/ diagnostictoolsbiomarkers117195.html
86. Morrison L. K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., Maisel A., Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea Journal of the American College of Cardiology 2002 39 2 202 209
87. Krger S., Papassotiriou J., Marre R., Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Intensive Care Medicine 2007 33 12 2069 2078
88. van den Berghe G., de Zegher F., Bouillon R., Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms Journal of Clinical Endocrinology Metabolism 1998 83 1827 1834
89. Christ-Crain M., Stolz D., Jutla S., Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia American Journal of Respiratory and Critical Care Medicine 2007 176 9 913 920
90. Christ-Crain M., Morgenthaler N. G., Stolz D., Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia Critical Care 2006 10 4 418
91. Schuetz P., Stolz D., Mueller B., Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia BMC Infectious Diseases 2008 8, article 22
92. Christ-Crain M., Mller B., Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators European Respiratory Journal 2007 30 3 556 573